ONCOTHERAPY SCIENCE, INC.

Autres langues OncoTherapy Science, Inc.

Actions

4564

JP3202150003

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
18 ^JPY	0,00 %		+5,88 %	-21,74 %

29/04	Le Premier ministre polonais Tusk appelle le procureur au sujet du scandale potentiel d'Orlen	RE
2023	OncoTherapy Science, Inc. annonce ses résultats pour l'exercice clos le 31 mars 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Poland's Tusk calls prosecutor over potential Orlen scandal	29/04
OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	22/04
OncoTherapy Science, Inc. announced that it expects to receive ¥3.78 million in funding from Long Corridor Asset Management Limited and another investor	05/04
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 \| Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.	05/12
OncoTherapy Science, Inc.(TSE:4564) dropped from S&P Global BMI Index	18/09/23
OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23
OncoTherapy Science, Inc. announced that it has received ¥95.95 million in funding	10/04/23
OncoTherapy Science, Inc. announced that it expects to receive ¥95.95 million in funding	24/03/23
OncoTherapy Science : Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer	13/09/22
OncoTherapy Science, Inc. announced that it has received ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	28/04/21
OncoTherapy Science, Inc. announced that it expects to receive ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	12/04/21
OncoTherapy Science : Japanese bio-venture starts development of COVID-19 peptide vaccine	01/10/20
OncoTherapy Science, Inc. announced that it has received ¥12.013 million in funding from Daiwa Securities Group Inc.	15/01/19
OncoTherapy Science, Inc. announced that it expects to receive ¥12.013 million in funding from Daiwa Securities Group Inc.	26/12/18
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company	14/07/17
OncoTherapy Science, Inc.(TSE:4564) added to Russell Global Index	29/06/15
OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A	31/07/13
Shionogi & Co. Signs Agreement with OncoTherapy Science Inc. for Cancer Peptide Vaccines	02/04/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Sécurisez et Augmentez la Performance de vos Investissements grâce à notre Équipe d'Experts à vos Côtés

Sécuriser mes Investissements

fermer